Dr. Michael Chu, MD
Claim this profileLondon Health Sciences Centre
Studies Coronary Artery Disease
Studies Stroke
17 reported clinical trials
26 drugs studied
Affiliated Hospitals
Clinical Trials Michael Chu, MD is currently running
Hemiarch vs Extended Arch Surgery
for Aortic Dissection
HEADSTART is a prospective, open-label, non-blinded, multicenter, randomized controlled trial that compares a composite of mortality and re-intervention in patients undergoing hemiarch and extended arch repair for acute DeBakey type 1 aortic dissection. Eligible patients will be randomized to one or the other surgical strategy and clinical and imaging outcome data will be collected over a 3 year follow up period.
Recruiting1 award N/A3 criteria
Heart Surgery
for Coronary Artery Disease
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy (STICH3C) trial is a prospective, unblinded, international multi-center randomized trial of 754 subjects enrolled in approximately 45 centers comparing revascularization by percutaneous coronary intervention (PCI) vs. coronary artery bypass grafting (CABG) in patients with multivessel/left main (LM) coronary artery disease (CAD) and reduced left ventricular ejection fraction (LVEF). The primary objective is to determine whether CABG compared to PCI is associated with a reduction in all-cause death, stroke, spontaneous myocardial infarction (MI), urgent repeat revascularization (RR), or heart failure (HF) readmission over a median follow-up of 5 years in patients with multivessel/LM CAD and ischemic left ventricular dysfunction (iLVSD). Eligible patients are considered by the local Heart Team appropriate and amenable for non-emergent revascularization by both modes of revascularization. The secondary objectives are to describe the early risks of both procedures, and a comprehensive set of patient-reported outcomes longitudinally.
Recruiting1 award N/A4 criteria
More about Michael Chu, MD
Clinical Trial Related4 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Michael Chu, MD has experience with
- Autologous CD19-directed Chimeric Antigen Receptor (CAR) T-cells
- Revascularization By PCI
- Revascularization By CABG
- Oral Anticoagulant
- Antiplatelet-only Strategy
- Multiple Arterial Grafting
Breakdown of trials Michael Chu, MD has run
Coronary Artery Disease
Stroke
Mitral Regurgitation
Mitral Valve Regurgitation
Mixed-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Chu, MD specialize in?
Michael Chu, MD focuses on Coronary Artery Disease and Stroke. In particular, much of their work with Coronary Artery Disease has involved treating patients, or patients who are undergoing treatment.
Is Michael Chu, MD currently recruiting for clinical trials?
Yes, Michael Chu, MD is currently recruiting for 8 clinical trials in London Ontario. If you're interested in participating, you should apply.
Are there any treatments that Michael Chu, MD has studied deeply?
Yes, Michael Chu, MD has studied treatments such as autologous CD19-directed chimeric antigen receptor (CAR) T-cells, Revascularization by PCI, Revascularization by CABG.
What is the best way to schedule an appointment with Michael Chu, MD?
Apply for one of the trials that Michael Chu, MD is conducting.
What is the office address of Michael Chu, MD?
The office of Michael Chu, MD is located at: London Health Sciences Centre, London, Ontario N6A 5A5 Canada. This is the address for their practice at the London Health Sciences Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.